369 related articles for article (PubMed ID: 32584021)
1. General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity against Amyloid β-Protein and α-Synuclein.
Jia L; Wang W; Yan Y; Hu R; Sang J; Zhao W; Wang Y; Wei W; Cui W; Yang G; Lu F; Zheng J; Liu F
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31182-31194. PubMed ID: 32584021
[TBL] [Abstract][Full Text] [Related]
2. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
Atsmon-Raz Y; Miller Y
ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
[TBL] [Abstract][Full Text] [Related]
3. Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity.
Di Giovanni S; Eleuteri S; Paleologou KE; Yin G; Zweckstetter M; Carrupt PA; Lashuel HA
J Biol Chem; 2010 May; 285(20):14941-14954. PubMed ID: 20150427
[TBL] [Abstract][Full Text] [Related]
4. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
5. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
6. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides.
Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J
ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676
[TBL] [Abstract][Full Text] [Related]
7. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
Briffa M; Ghio S; Neuner J; Gauci AJ; Cacciottolo R; Marchal C; Caruana M; Cullin C; Vassallo N; Cauchi RJ
Neurosci Lett; 2017 Jan; 638():12-20. PubMed ID: 27919712
[TBL] [Abstract][Full Text] [Related]
8. De novo designed protein inhibitors of amyloid aggregation and seeding.
Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734
[TBL] [Abstract][Full Text] [Related]
9. The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation.
Galzitskaya OV; Grishin SY; Glyakina AV; Dovidchenko NV; Konstantinova AV; Kravchenko SV; Surin AK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835194
[TBL] [Abstract][Full Text] [Related]
10. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
[TBL] [Abstract][Full Text] [Related]
11. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
Werner T; Horvath I; Wittung-Stafshede P
J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
[TBL] [Abstract][Full Text] [Related]
13. Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers.
Bisi N; Pinzi L; Rastelli G; Tonali N
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338465
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
[TBL] [Abstract][Full Text] [Related]
15. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
Williams SM; Schulz P; Sierks MR
Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
[TBL] [Abstract][Full Text] [Related]
16. Amyloids on Membrane Interfaces: Implications for Neurodegeneration.
Mahakud AK; Shaikh J; Rifa Iqbal VV; Gupta A; Tiwari A; Saleem M
J Membr Biol; 2022 Dec; 255(6):705-722. PubMed ID: 35670831
[TBL] [Abstract][Full Text] [Related]
17. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.
Ge X; Yang Y; Sun Y; Cao W; Ding F
ACS Chem Neurosci; 2018 May; 9(5):967-975. PubMed ID: 29378116
[TBL] [Abstract][Full Text] [Related]
18. Sequence and structure-based peptides as potent amyloid inhibitors: A review.
Mitra A; Sarkar N
Arch Biochem Biophys; 2020 Nov; 695():108614. PubMed ID: 33010227
[TBL] [Abstract][Full Text] [Related]
19. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
[TBL] [Abstract][Full Text] [Related]
20. Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease.
Li J; Zhu M; Manning-Bog AB; Di Monte DA; Fink AL
FASEB J; 2004 Jun; 18(9):962-4. PubMed ID: 15059976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
